Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016

BACKGROUND: Germline pathogenic variants in BRCA1/2 have been established in hereditary breast and ovarian cancer (HBOC) syndrome and result in significantly elevated lifetime risk of ovarian cancer. Risk reduction interventions are presently the only effective means of improving survival and specia...

Descripción completa

Detalles Bibliográficos
Autores principales: Adolph, Lauren, Warias, Ashley, Stairs, Jocelyn, Collins-McNeil, Kelly, Penney, Lynette, Kieser, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245201/
https://www.ncbi.nlm.nih.gov/pubmed/35768821
http://dx.doi.org/10.1186/s12905-022-01844-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245201/
https://www.ncbi.nlm.nih.gov/pubmed/35768821
http://dx.doi.org/10.1186/s12905-022-01844-5

Ejemplares similares